Assistive Robotics Company Bangbang Robotics Nets CNY 100 Mn in Series B Round

Healthcare Author: Siren Chen Jun 30, 2022 09:50 PM (GMT+8)

The supporting facilities for disabled groups are a market in huge demand, and the population aging is accelerating the travel assistance demand.

Health care robot

Bangbang Robotics (Chinese: 邦邦机器人) announced the completion of  Series B financing worth nearly CNY 100 million. The fund was jointly led by Lake Bleu Capital (Chinese: 清池资本) and BioTrack Capital (Chinese: 博远资本), followed by 01VC (Chinese: 零一创投) and the existing shareholder Long Hill Capital (Chinese: 长岭资本).

The fund will mainly be used to accelerate the production and implementation of new products. At the same time, the company will actively promote its products to go abroad.

It is noteworthy that rehabilitation and elderly care are key areas mentioned in the  '14th Five-Year Plan' National Health Plan. With the aging population in China, there is bound to be a market for high-quality assistive products and rehabilitation services.

However, crutches and manual wheelchairs were the only tools among people with lower-limb movement disorders for a long time. In the later stage, there were electric wheelchairs, scooters, and power-assisted products. With the rapid development of chip technology, new materials, high-performance motors and the internet of things, intelligent walking-aid robots have also been created to meet the market needs.

Bangbang Robotics is one of the new generation brands. Up to now, the China Disabled Persons’ Federation and the Department of Labour have included Bangbang robots in the relevant recommended catalog, and many cities have also listed the company's product in the long-term care insurance. Bangbang’s product has been sold to nearly 20 countries over five continents.

Bangbang Robotics competitive includes Mile Bot (Chinese: 迈步机器人), AI Doctor (Chinese: 智弈生) and Fourier Intelligence (Chinese: 傅利叶智能).